RY_SW01 Cell Injection Therapy in Active Lupus Nephritis

Clinical trial NCT06058078 · RECRUITING

Trial details

NCT number: NCT06058078
Sponsor: Jiangsu Renocell Biotech Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2023-08-17
Primary completion: 2025-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.